IFNγ-inducible Gbp4 and Irgb6 contribute to experimental cerebral malaria pathology in the olfactory bulb

Julia Matsuo-Dapaah1,2, Jalal Alshaweesh1, Michelle Sue Jann Lee1

  • 1Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo, Japan.

Mbio
|July 3, 2025
PubMed

Insights

Interferon-inducible GTPases, Irgb6 and Gbp4, drive experimental cerebral malaria (ECM) pathology by impairing antigen presentation in the olfactory bulb. Mice lacking these GTPases show improved survival, revealing their dual role in host defense and disease.

Area of Science:

  • Immunology
  • Neuroscience
  • Infectious Diseases

Background:

  • Cerebral malaria (CM) is a severe complication of Plasmodium falciparum infection.
  • The precise pathogenesis of CM, particularly early mechanisms, remains incompletely understood.
  • The olfactory bulb (OB) is implicated in experimental cerebral malaria (ECM) immunopathology.

Purpose of the Study:

  • To investigate molecular mechanisms driving early ECM pathogenesis.
  • To identify key genes associated with disease onset using transcriptomic profiling of the OB.
  • To elucidate the role of interferon (IFN)-inducible GTPases in ECM.

Main Methods:

  • Transcriptomic profiling of the olfactory bulb in an ECM mouse model.
  • Generation and analysis of Gbp4 knockout (Gbp4-/-), Irgb6 knockout (Irgb6-/-), and double knockout (Irgb6-/- Gbp4-/-) mice.
  • Assessment of T cell infiltration, functionality, antigen presentation, and parasite burden in the brain.

Main Results:

  • Early upregulation of IFN-inducible GTPases Irgb6 and Gbp4 was observed in the OB.
  • Gbp4 and Irgb6 were found to play a pathological role in ECM.
  • Double-knockout mice exhibited impaired antigen presentation, altered T cell dynamics, and enhanced survival.

Conclusions:

  • Gbp4 and Irgb6 are critical in early ECM immunopathogenesis by modulating antigen presentation in the OB.
  • These GTPases influence immune cell dynamics and contribute to pathological inflammation.
  • Findings offer insights into CM mechanisms and potential therapeutic targets related to antigen presentation.